Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine for hemodynamic stabilization after intraoperative vasopressin injection during laparoscopic myomectomy
ChiCTR2500101771Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lidocaine in Fibromyoma (LM) (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Degree of blood pressure fluctuation after vasopressin injection. Started Apr 2025; status: recruiting.
02
Drugs
lidocaine
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on ChiCTR2500101771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101771.